NANOSTRING TECHNOLOGIES, INC. AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 2nd, 2020 • NanoString Technologies Inc • Biological products, (no disgnostic substances) • Washington
This Amendment to Executive Employment Agreement (this “Amendment”) is made by and between Joseph Beechem (“Executive”) and NanoString Technologies, Inc., a Delaware corporation (the “Company” and together with Executive, the “Parties”) on the dates set forth below.
NANOSTRING TECHNOLOGIES, INC. AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 2nd, 2020 • NanoString Technologies Inc • Biological products, (no disgnostic substances) • Washington
This Amendment to Executive Employment Agreement (this “Amendment”) is made by and between K. Thomas Bailey (“Executive”) and NanoString Technologies, Inc., a Delaware corporation (the “Company” and together with Executive, the “Parties”) on the dates set forth below.
PERFORMANCE-BASED RESTRICTED STOCK UNIT AGREEMENTPerformance-Based Restricted Stock Unit Agreement • March 2nd, 2020 • NanoString Technologies Inc • Biological products, (no disgnostic substances) • Washington
Unless otherwise defined herein, the terms defined in the NanoString Technologies, Inc. 2013 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Performance-Based Restricted Stock Unit Agreement (the “Award Agreement”), which includes the Notice of Performance-Based Restricted Stock Unit Grant (the “Notice of Grant”) and Terms and Conditions of Performance-Based Restricted Stock Unit Grant, attached hereto as Exhibit A.
NANOSTRING TECHNOLOGIES, INC. AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 2nd, 2020 • NanoString Technologies Inc • Biological products, (no disgnostic substances) • Washington
This Amendment to Executive Employment Agreement (this “Amendment”) is made by and between J. Chad Brown (“Executive”) and NanoString Technologies, Inc., a Delaware corporation (the “Company” and together with Executive, the “Parties”) on the dates set forth below.
AMENDMENT #1 TO COLLABORATION AGREEMENTCollaboration Agreement • March 2nd, 2020 • NanoString Technologies Inc • Biological products, (no disgnostic substances)
This Amendment #1 (this “Amendment”) to the parties’ Collaboration Agreement (the “Agreement”) dated as of August 4, 2017 is made by and between NanoString Technologies, Inc. (“NanoString”), and Lam Research Corporation (“Lam”) as of May 28, 2019 (the “Amendment Effective Date”). All capitalized terms used but not defined herein shall have the same meaning assigned to them in the Agreement.
